乳腺X线摄影深度学习模型与传统乳腺癌风险模型在补充MRI筛查患者中的诊断准确性比较
本回顾性研究纳入2017年9月至2020年9月四家机构连续接受乳腺癌筛查MRI的2168例女性(共4247次高风险筛查MRI检查),比较基于乳腺X线摄影的深度学习5年风险模型与传统Tyrer-Cuzick和BCRAT模型的诊断准确性。深度学习模型判定为高风险的患者,其MRI筛查的癌症检出率和阳性预测值均高于传统模型判定为高风险的患者。
要点
- 深度学习模型高风险组CDR为20.6/1000次检查,高于TC模型6.0/1000次和BCRAT模型6.8/1000次。
- 深度学习模型高风险组PPV1、PPV2、PPV3分别为14.6%、32.4%、36.4%,均高于传统模型高风险组。
- 深度学习模型基于最近一次筛查乳腺X线摄影生成5年风险评分,绝对评分≥2.3为风险增高、≥6.6为高风险。
核心结论
- 在补充MRI筛查人群中,基于乳腺X线摄影的深度学习风险模型判定为高风险的患者,其MRI筛查的癌症检出率和阳性预测值均高于传统风险模型判定为高风险的患者。
研究设计与样本
- 回顾性研究,纳入2017年9月至2020年9月四家机构连续接受乳腺癌筛查MRI的2168例女性(共4247次高风险筛查MRI检查),中位年龄54岁(IQR 48-60岁);以Tyrer-Cuzick和BCRAT 5年及终生风险模型以及基于最近一次筛查乳腺X线摄影的深度学习5年模型评估风险,采用逻辑回归模型比较模型准确性指标。
诊断标准与关键数值
- 传统5年模型风险评分≥1.67%定义为风险增高,传统终生模型评分≥20%定义为高风险;深度学习模型绝对评分≥2.3定义为风险增高、≥6.6定义为高风险。深度学习模型高风险组CDR为20.6/1000次检查(95%CI 11.8-35.6),高于TC终生模型高风险组6.0/1000次(95%CI 2.9-12.3;P<.01)和BCRAT终生模型高风险组6.8/1000次(95%CI 2.9-15.8;P=.04)。深度学习模型高风险组PPV1为14.6%、PPV2为32.4%、PPV3为36.4%,高于TC终生模型高风险组(PPV1 5.0%、PPV2 12.7%、PPV3 13.5%;P值范围.02-.03)和BCRAT终生模型高风险组(PPV1 5.5%、PPV2 11.1%、PPV3 12.5%;P值范围.02-.05)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Access to supplemental screening breast MRI is determined using traditional risk models, which are limited by modest predictive accuracy. Purpose To compare the diagnostic accuracy of a mammogram-based deep learning (DL) risk assessment model to that of traditional breast cancer risk models in patients who underwent supplemental screening with MRI. Materials and Methods This retrospective study included consecutive patients undergoing breast cancer screening MRI from September 2017 to September 2020 at four facilities. Risk was assessed using the Tyrer-Cuzick (TC) and National Cancer Institute Breast Cancer Risk Assessment Tool (BCRAT) 5-year and lifetime models as well as a DL 5-year model that generated a risk score based on the most recent screening mammogram. A risk score of 1.67% or higher defined increased risk for traditional 5-year models, a risk score of 20% or higher defined high risk for traditional lifetime models, and absolute scores of 2.3 or higher and 6.6 or higher defined increased and high risk, respectively, for the DL model. Model accuracy metrics including cancer detection rate (CDR) and positive predictive values (PPVs) (PPV of abnormal findings at screening [PPV1], PPV of biopsies recommended [PPV2], and PPV of biopsies performed [PPV3]) were compared using logistic regression models. Results This study included 2168 women who underwent 4247 high-risk screening MRI examinations (median age, 54 years [IQR, 48-60 years]). CDR (per 1000 examinations) was higher in patients at high risk according to the DL model (20.6 [95% CI: 11.8, 35.6]) than according to the TC (6.0 [95% CI: 2.9, 12.3]; P < .01) and BCRAT (6.8 [95% CI: 2.9, 15.8]; P = .04) lifetime models. PPV1, PPV2, and PPV3 were higher in patients identified as high risk by the DL model (PPV1, 14.6%; PPV2, 32.4%; PPV3, 36.4%) than those identified as high risk with the TC (PPV1, 5.0%; PPV2, 12.7%; PPV3, 13.5%; P value range, .02-.03) and BCRAT (PPV1, 5.5%; PPV2, 11.1%; PPV3, 12.5%; P value range, .02-.05) lifetime models. Conclusion Patients identified as high risk by a mammogram-based DL risk assessment model showed higher CDR at breast screening MRI than patients identified as high risk with traditional risk models. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Bae in this issue.
引用
- Lamb LR, Mercaldo SF, Ghaderi K, et al. Comparison of the Diagnostic Accuracy of Mammogram-based Deep Learning and Traditional Breast Cancer Risk Models in Patients Who Underwent Supplemental Screening with MRI. Radiology. 2023. PMID: 37724967. doi:10.1148/radiol.223077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。